ABC-type DLBCL is characterized by constitutive activation of the NF-κB signaling pathway and has a poorer prognosis with standard R-CHOP chemotherapy compared with GCB-type DLBCL [5]. Here, NFKB1 is linked to diffuse large B-cell lymphoma.